ES2103422T3 - Uso de bilobalida y sus derivados para tratar una infeccion en un individuo y composiciones farmaceuticas destinadas a dicho uso. - Google Patents

Uso de bilobalida y sus derivados para tratar una infeccion en un individuo y composiciones farmaceuticas destinadas a dicho uso.

Info

Publication number
ES2103422T3
ES2103422T3 ES93301010T ES93301010T ES2103422T3 ES 2103422 T3 ES2103422 T3 ES 2103422T3 ES 93301010 T ES93301010 T ES 93301010T ES 93301010 T ES93301010 T ES 93301010T ES 2103422 T3 ES2103422 T3 ES 2103422T3
Authority
ES
Spain
Prior art keywords
bilobalide
infection
individual
treat
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93301010T
Other languages
English (en)
Inventor
Ezio Bombardelli
Mario Ghione
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Indena SpA
Original Assignee
Indena SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena SpA filed Critical Indena SpA
Application granted granted Critical
Publication of ES2103422T3 publication Critical patent/ES2103422T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA INVENCION PROPORCIONA UN METODO DE TRATAMIENTO DE UNA INFECCION EN UN INDIVIDUO, POR ADMINISTRACION DE UNA DOSIS EFECTIVA DE BILOBALIDO O DE UN DERIVADO ACEPTABLE FARMACOLOGICAMENTE DEL MISMO. LA ACTIVIDAD CONTRA LA INFECCION POR PNEUMOCYSTIS CARINII TIENE PRINCIPAL UTILIDAD EN EL TRATAMIENTO DE INFECCIONES ASOCIADAS CON EL SIDA. EL BILOBALIDO PUEDE SER ADMINISTRADO SISTEMICA O TOPICAMENTE DE ACUERDO CON LA INVENCION. PARA EL USO SISTEMICO, SE PUEDEN USAR LAS RUTAS DE ADMINISTRACION ORAL Y PARENTERAL.
ES93301010T 1992-02-13 1993-02-12 Uso de bilobalida y sus derivados para tratar una infeccion en un individuo y composiciones farmaceuticas destinadas a dicho uso. Expired - Lifetime ES2103422T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929202993A GB9202993D0 (en) 1992-02-13 1992-02-13 Novel pharmaceutical uses of bilobalide and derivatives thereof and pharmaceutical compositions adapted for such use

Publications (1)

Publication Number Publication Date
ES2103422T3 true ES2103422T3 (es) 1997-09-16

Family

ID=10710286

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93301010T Expired - Lifetime ES2103422T3 (es) 1992-02-13 1993-02-12 Uso de bilobalida y sus derivados para tratar una infeccion en un individuo y composiciones farmaceuticas destinadas a dicho uso.

Country Status (12)

Country Link
US (1) US5264216A (es)
EP (1) EP0556051B1 (es)
JP (1) JP3156212B2 (es)
KR (1) KR100251394B1 (es)
AT (1) ATE152911T1 (es)
CA (1) CA2089309C (es)
DE (1) DE69310565T2 (es)
DK (1) DK0556051T3 (es)
ES (1) ES2103422T3 (es)
GB (1) GB9202993D0 (es)
GR (1) GR3023414T3 (es)
SG (1) SG48723A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6379714B1 (en) 1995-04-14 2002-04-30 Pharmaprint, Inc. Pharmaceutical grade botanical drugs
US6036696A (en) 1997-12-19 2000-03-14 Stryker Technologies Corporation Guide-pin placement device and method of use
EP1861021A1 (en) * 2005-03-17 2007-12-05 Smith and Nephew, Inc. Medical securing member placement system

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3338995A1 (de) * 1983-10-27 1985-05-09 Dr. Willmar Schwabe GmbH & Co, 7500 Karlsruhe Bilobalid enthaltende arzneimittel
IT1238684B (it) * 1990-02-09 1993-09-01 Indena Spa Derivati del bilobalide,loro usi e formulazioni che li contegono

Also Published As

Publication number Publication date
GB9202993D0 (en) 1992-03-25
EP0556051A1 (en) 1993-08-18
KR100251394B1 (ko) 2000-05-01
CA2089309C (en) 2004-11-30
DK0556051T3 (da) 1997-07-28
US5264216A (en) 1993-11-23
SG48723A1 (en) 1998-05-18
GR3023414T3 (en) 1997-08-29
HK1000276A1 (en) 1998-02-20
EP0556051B1 (en) 1997-05-14
ATE152911T1 (de) 1997-05-15
DE69310565T2 (de) 1997-12-18
DE69310565D1 (de) 1997-06-19
JP3156212B2 (ja) 2001-04-16
KR930017577A (ko) 1993-09-20
JPH0624974A (ja) 1994-02-01
CA2089309A1 (en) 1993-08-14

Similar Documents

Publication Publication Date Title
ES2179040T3 (es) Utilizacion de 5-fluoro-2'-desoxi-3'-tiacitidina para el tratamiento de la hepatitis b.
DE69214938D1 (de) Mittel zur topischen verabreichung von arzneiwirkstoffen
ATE211387T1 (de) Oral 1alpha-hydroxyprevitamin d
CO5251419A1 (es) Composiciones nanoparticuladas de eplerenona
ES2083668T3 (es) Combinaciones antiviricas que contienen analogos de nucleosidos.
DE69521693D1 (de) Taxanderivate enthaltende arzneizubereitungen
ITRM920270A0 (it) Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale.
IT1235153B (it) Uso dell'acetil l-carnitina nel trattamento terapeutico della cataratta e composizioni farmaceutiche utili in tale trattamento
ATE50499T1 (de) Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe.
ATE173627T1 (de) Medizinische zusammensetzung
MY108146A (en) Medicaments for treating inflammatory conditions or for analgesia
IT1264530B (it) Impiego dei polisaccaridi nelle neuropatie atrofico degenerative
ITRM910002A1 (it) Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
FR2674754B1 (fr) Composition medicamenteuse micronisee.
IT1256623B (it) Antagonisti delle tachichinine, procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche
ES2103422T3 (es) Uso de bilobalida y sus derivados para tratar una infeccion en un individuo y composiciones farmaceuticas destinadas a dicho uso.
IT1249650B (it) N-(5-tioxo-l-prolil)-l-cisteina e suoi derivati, loro preparazione ed impiego terapeutico
ES2072386T3 (es) Derivados del penciclovir para el tratamiento de las infecciones de hepatitis-b.
ES2128353T3 (es) Composicion topica que contiene penciclovir.
ATE189395T1 (de) Verwendung von protease nexin-i als mittel gegen entzündungen
ATE145333T1 (de) Hirudin enthaltende orale arzneimittel
IT1249060B (it) Composizione farmaceutica ad uso topico per il trattamento di cicatrizzazione e riepitelizzazione di ulcere flebostatiche croniche.
ES2135424T3 (es) Composicion oral a base de ibuprofeno.
ES2057542T3 (es) Agentes terapeuticos.
ITMI931598A1 (it) Uso terapeutico della fosfocreatina

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 556051

Country of ref document: ES